Pelthos Therapeutics Inc. · AMEX:PTHS
Pauls Matthew sold 786 Pelthos Therapeutics Inc. shares (Form 4)
Traded Apr 2, 2026 · Filed Apr 6, 2026
On Apr 2, 2026, Pauls Matthew (Director) sold 786 Pelthos Therapeutics Inc. shares at an average US$20.92 for US$16,440 under a trading plan, leaving 15,150 shares. Filed Apr 6, 2026 (Form 4).
- Sold
- 786 shares
- Price
- US$20.92 average (US$20.52 to US$21.36)
- Value
- US$16,440
- Holding after
- 15,150 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 2, 2026 | Common Stock | Sale | 415 | US$20.52 | 15,521 | Direct |
| Apr 2, 2026 | Common Stock | Sale | 371 | US$21.36 | 15,150 | Direct |
Source
Related
- Pelthos Therapeutics Inc.
- Pauls Matthew
- Pelthos Therapeutics Inc. shareholders
- Form 4 · Pauls Matthew · Oct 6, 2026
- Form 4 · Pauls Matthew · Jul 7, 2026
- Form 4/A · Pauls Matthew · Apr 1, 2026
- Form 4 · Friedberg Ezra M · Oct 6, 2026
- Form 4 · Greenleaf Peter · Oct 6, 2026
- Form 4 · Friedberg Ezra M · Jul 7, 2026
- Form 4 · Greenleaf Peter · Jul 7, 2026
- Form 4 · Friedberg Ezra M · Jun 17, 2026